Drugs / Human allogeneic mesenchymal bone marrow derived stem cells
Human allogeneic mesenchymal bone marrow derived stem cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03602872 | Aug 2019 → Apr 2020 | osteoarthritis, knee | Clinica Santa Clarita, Mexico | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Human allogeneic mesenchymal bone marrow derived stem cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03602872 ↗ |
| Modality | Cell therapy | “Human allogeneic mesenchymal bone marrow derived stem cells” NCT03602872 ↗ |
| Route | Other | “The route of administration is intraarticular.” NCT03602872 ↗ |